Science is magic that works
remetide
Ask us about research grade peptides !
More than 1000 peptides to offer!
Searching for top-tier peptide manufacturing and supply? Look no further. At Remetide Global, we specialize in delivering premium-quality peptides alongside a curated selection of chemical agents for research and development. Our deep-rooted expertise in the peptide industry means we cater to over 200 clients globally, offering not just top-of-the-line peptide synthesis, but also unmatched value. Why Partner with Remetide for Peptide Solutions?
- Disclaimer: RUO/IUO Research/Investigational Use Only (except FDA registered/approved molecules)
- Excellence in Quality: Our peptide manufacturing follows cGMP strictly.
- Consistent & Reliable: Trust Remetide for a steadfast supply of peptide products. Our consistency is what sets us apart.
- Driving Peptide Innovation: At Remetide, we’re not just suppliers—we’re trailblazers. Our innovative approach ensures we’re always ahead in the peptide market, meeting future demands today.
- Collaborations That Count: We amplify our peptide offerings through strategic partnerships with medical experts, top-tier universities, and an ever-evolving R&D platform. (e
Latest News
From The Blog
Latest FDA Regulations on Peptides Used as Bulk Substances for 503A or 503B Compounding Pharmacies
The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing
GLP-1 Products for Weight Loss: The Latest
GLP-1 Products for Weight Loss: The Latest Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs that mimic the effects of the naturally occurring GLP-1
A new peptide for the treatment of non-small cell lung cancer
SRI International researchers have developed a new peptide for the treatment of non-small cell lung cancer, the most common form of lung cancer. The peptide
Peptide-based Gastrointestinal Disorders Therapeutics market is increasing
The Peptide-based Gastrointestinal Disorders Therapeutics market is increasing due to the rising prevalence of gastrointestinal issues, growing demand for targeted and personalized treatments, and increased
Peptide kills bacteria without creating superbugs
Antibiotics are used to treat and prevent infection, but if a wound is not treated, harmful bacteria can develop a resistance to them. a new
A new peptide developed by UCI suppresses the lung inflammation
Researchers at the University of California, Irvine have developed a new peptide that has been found to effectively suppress the lung inflammation associated with Acute
Satisfied customers globally
Fast lead time
Competitive price
product
Latest FDA Regulations on Peptides Used as Bulk Substances for 503A or 503B Compounding Pharmacies
The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing
GLP-1 Products for Weight Loss: The Latest
GLP-1 Products for Weight Loss: The Latest Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs that mimic the effects of the naturally occurring GLP-1
A new peptide for the treatment of non-small cell lung cancer
SRI International researchers have developed a new peptide for the treatment of non-small cell lung cancer, the most common form of lung cancer. The peptide
Peptide-based Gastrointestinal Disorders Therapeutics market is increasing
The Peptide-based Gastrointestinal Disorders Therapeutics market is increasing due to the rising prevalence of gastrointestinal issues, growing demand for targeted and personalized treatments, and increased
product
Latest FDA Regulations on Peptides Used as Bulk Substances for 503A or 503B Compounding Pharmacies
The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing
GLP-1 Products for Weight Loss: The Latest
GLP-1 Products for Weight Loss: The Latest Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs that mimic the effects of the naturally occurring GLP-1
A new peptide for the treatment of non-small cell lung cancer
SRI International researchers have developed a new peptide for the treatment of non-small cell lung cancer, the most common form of lung cancer. The peptide
Peptide-based Gastrointestinal Disorders Therapeutics market is increasing
The Peptide-based Gastrointestinal Disorders Therapeutics market is increasing due to the rising prevalence of gastrointestinal issues, growing demand for targeted and personalized treatments, and increased
Mission: Remetide Global commits to fueling breakthroughs by delivering the pinnacle of peptide products, fostering innovation, and fortifying global research endeavors.
Your global entry to peptide industry.
VISION: “GUIDED BY EXCELLENCE AND PARTNERSHIP, WE ENVISION BEING THE WORLD’S TRUSTED CORNERSTONE FOR PEPTIDE SOLUTIONS, CATALYZING TRANSFORMATIVE SCIENTIFIC MILESTONES FOR GENERATIONS TO COME.”
product
Latest FDA Regulations on Peptides Used as Bulk Substances for 503A or 503B Compounding Pharmacies
The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing
GLP-1 Products for Weight Loss: The Latest
GLP-1 Products for Weight Loss: The Latest Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs that mimic the effects of the naturally occurring GLP-1
A new peptide for the treatment of non-small cell lung cancer
SRI International researchers have developed a new peptide for the treatment of non-small cell lung cancer, the most common form of lung cancer. The peptide
Peptide-based Gastrointestinal Disorders Therapeutics market is increasing
The Peptide-based Gastrointestinal Disorders Therapeutics market is increasing due to the rising prevalence of gastrointestinal issues, growing demand for targeted and personalized treatments, and increased
product
Latest FDA Regulations on Peptides Used as Bulk Substances for 503A or 503B Compounding Pharmacies
The FDA’s latest regulations on peptides are focused on ensuring the safety and efficacy of these drugs. In recent years, there has been a growing
GLP-1 Products for Weight Loss: The Latest
GLP-1 Products for Weight Loss: The Latest Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs that mimic the effects of the naturally occurring GLP-1
A new peptide for the treatment of non-small cell lung cancer
SRI International researchers have developed a new peptide for the treatment of non-small cell lung cancer, the most common form of lung cancer. The peptide
Peptide-based Gastrointestinal Disorders Therapeutics market is increasing
The Peptide-based Gastrointestinal Disorders Therapeutics market is increasing due to the rising prevalence of gastrointestinal issues, growing demand for targeted and personalized treatments, and increased
The products are constantly updated